Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd.: Announcement of reply to regulatory inquiry letter regarding information disclosure of 2023 annual report.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.